Agilent Technolog…
USUSDAgilent Technologies Inc (LSE:0HAV) — Biotechnology: Laboratory Analytical Instruments. Anzahl der Börsen, an denen die Aktien des Unternehmens gehandelt werden: 2. Auf dieser Seite: Kurs und Chart, Dividenden, größte Aktionäre und Entwicklung der Aktienanzahl.
Über das Unternehmen
- Website
- agilent.com
- Sektor
- Industrials · Biotechnology: Laboratory Analytical Instruments
- Hauptsitz
- Santa Clara, United States
- CEO
- Padraig McDonnell
- Mitarbeiter
- 17 671
- Gegründet
- 1999
- Ausstehende Aktien
- 281.93 Mio. Stand 2026-08-26
- Streubesitz
- 280.96 Mio.
- Marktkapitalisierung
- 49.4 Mrd. USD
- Insider
- 0.2%
- Institutionelle Anleger
- 95.5%
- Branche (SIC)
- Laboratory Analytical Instruments
- ISIN
- US00846U1016
- LEI
- QUIX8Y7A2WP0XRMW7G29
- Ausschüttungsquote
- 19.9%
- FCF
- 1.27 Mrd. USD23%
- Schulden
- 3.95 Mrd. USD1.7 J. FCF
- Dividendenserie
- 14 J.
- Gewinn, FCF und gezahlte Dividenden — für die 12 Monate bis 31.07.2026 (letzter Bericht des Unternehmens).
Beschreibung
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems. This segment is also involved in the genomics, contract development and manufacturing organization, pathology, companion diagnostics, and biomolecular analysis businesses. The Agilent CrossLab segment provides various services, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, consulting, and other custom services. This segment also offers consumables, including gas chromatography and liquid chromatography columns, sample preparation products, custom chemistries, and various laboratory supplies; software and informatics solutions comprising software for instrument control, data acquisition, data analysis, secure storage of results, and laboratory information and workflow management; and OpenLab laboratory software, an open software platform that enables customers to capture, analyze, and share scientific data throughout the lab and across the enterprise. In addition, it provides automated sample preparation solutions, such as liquid handling, plate management, consumables, and scheduling software. The Applied Markets segment offers products in the areas of gas chromatography, mass spectrometry, spectroscopy, vacuum technology, and remarketed instruments. It markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
Dividenden
Agilent Technologies Inc (A) zahlt vierteljährlich Dividenden. Pro Jahr (12 Monate bis einschließlich der zuletzt angekündigten Zahlung): 1.02 USD pro Aktie (Zahlungen: 4). Das entspricht etwa 0.60% des aktuellen Aktienkurses. Basierend auf der Zahlungshistorie wird der nächste Ex-Dividenden-Tag um den 05.01.2027 erwartet. Ununterbrochene Dividendengeschichte: 14 Jahre.
| Ex-tag | Auszahlung | Betrag | % | Typ | Ticker |
|---|---|---|---|---|---|
| 2026-10-06 | 2026-10-28 | 0.2550 USD | 0.1/0.6 % | vierteljährlich | US:A |
| 2026-06-30 | 2026-07-22 | 0.2550 USD | 0.1/0.6 % | vierteljährlich | US:A |
| 2026-03-31 | 2026-04-22 | 0.2550 USD | 0.1/0.6 % | vierteljährlich | US:A |
| 2026-01-06 | 2026-01-28 | 0.2550 USD | 0.1/0.6 % | vierteljährlich | US:A |
| 2025-09-30 | 2025-10-22 | 0.2480 USD | 0.1/0.6 % | vierteljährlich | US:A |
| 2025-07-01 | 2025-07-23 | 0.2480 USD | 0.1/0.6 % | vierteljährlich | US:A |
| 2025-04-01 | 2025-04-23 | 0.2480 USD | 0.1/0.6 % | vierteljährlich | US:A |
| 2024-12-31 | 2025-01-22 | 0.2480 USD | 0.1/0.6 % | vierteljährlich | US:A |
| 2024-10-01 | 2024-10-23 | 0.2360 USD | 0.1/0.6 % | vierteljährlich | US:A |
| 2024-07-02 | 2024-07-24 | 0.2360 USD | 0.1/≈0.6 % | vierteljährlich | US:A |
| 2024-04-01 | 2024-04-24 | 0.2360 USD | 0.1/≈0.6 % | vierteljährlich | US:A |
| 2023-12-29 | 2024-01-24 | 0.2360 USD | 0.1/0.1 % | vierteljährlich | US:A |
Größte Anteilseigner
| Inhaber | Anteil | Aktien | Berichtsdatum |
|---|---|---|---|
| Blackrock Inc. | 9.08% | 25.6 Mio. | 2026-06-30 |
| Vanguard Capital Managem… | 6.54% | 18.45 Mio. | 2026-06-30 |
| Vanguard Portfolio Manag… | 5.12% | 14.44 Mio. | 2026-06-30 |
| State Street Corporation | 4.56% | 12.85 Mio. | 2026-06-30 |
| Massachusetts Financial… | 3.55% | 10.01 Mio. | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 3.18% | 8.96 Mio. | 2026-06-30 |
| T. Rowe Price Investment… | 2.75% | 7.76 Mio. | 2026-06-30 |
| Geode Capital Management… | 2.69% | 7.6 Mio. | 2026-06-30 |
| Wellington Management Gr… | 2.64% | 7.45 Mio. | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.6% | 7.32 Mio. | 2026-06-30 |
| Deutsche Bank AG | 2.49% | 7.01 Mio. | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.17% | 6.12 Mio. | 2026-06-30 |
| Bank Of New York Mellon… | 1.86% | 5.23 Mio. | 2026-06-30 |
| T. Rowe Price Mid-Cap Gr… | 1.46% | 4.11 Mio. | 2026-06-30 |
| VANGUARD SPECIALIZED FUN… | 1.36% | 3.82 Mio. | 2026-04-30 |
| iShares Trust-iShares Co… | 1.35% | 3.81 Mio. | 2026-07-31 |
| Fidelity Concord Street… | 1.3% | 3.65 Mio. | 2026-07-31 |
| SPDR S&P 500 ETF TRUST-S… | 1.23% | 3.46 Mio. | 2026-08-31 |
| VANGUARD INDEX FUNDS-Van… | 0.95% | 2.68 Mio. | 2026-06-30 |
| MFS SERIES TRUST X-MFS I… | 0.78% | 2.2 Mio. | 2026-05-31 |
| MCMAHON ROBERT W (Chief… | ≈0.06% | 172 191 | 2025-03-05 |
| ANCHER JENSEN HENRIK (Of… | ≈0.03% | 90 674 | 2024-11-27 |
| MCDONNELL PADRAIG (Chief… | ≈0.02% | 69 028 | 2025-11-18 |
| KOH BOON HWEE (Director) | ≈0.02% | 63 184 | 2026-03-19 |
| SCANGOS GEORGE A (Direct… | ≈0.01% | 41 750 | 2026-03-19 |
| PODOLSKY DANIEL K (Direc… | ≈0.01% | 38 179 | 2026-03-19 |
| RIEMANN ANGELICA (Office… | ≈0.01% | 29 556 | 2025-11-18 |
| RATAJ SUE H (Director) | ≈0.01% | 23 617 | 2026-03-19 |
| FIELDS-KUNZ HEIDI (Direc… | — | — | 2025-03-14 |
| GONSALVES RODNEY (Office… | — | — | 2025-11-26 |
